Eric Dube Named to The Medicine Maker’s ‘The Power List 2022’

Monday, May 2, 2022 — Congratulations to our president and CEO, Eric Dube, Ph.D., for being named to The Medicine Maker’s ‘The Power List 2022’. Eric drives innovation by championing “continued, relentless attention to understanding the unique experiences of all patients and bringing those perspectives into everything we do.” Eric explains his philosophy on the importance of integrating the patient and caregiver voice early and often in the drug development process at themedicinemaker.com.

In June 2022, ‘The Power List 2022’  recipients, including Eric, were asked to address the biggest lessons that the pharma industry has learned from the COVID-19 pandemic. Eric spoke to solving the crisis of health equity and the work Travere is doing to help address racial and socioeconomic disparities among people living with rare disease.